Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas
1998

RhoC Gene Overexpression in Pancreatic Cancer

Sample size: 33 publication Evidence: moderate

Author Information

Author(s): H Suwal, G Ohshio, T Imamura, G Watanabe, S Arii, M Imamura, S Narumiya, H Hiai, M Fukumoto

Primary Institution: Kyoto University

Hypothesis

The study investigates the role of rhoC gene expression in the progression of pancreatic ductal adenocarcinoma.

Conclusion

Overexpression of the rhoC gene is associated with poorer prognosis in patients with pancreatic adenocarcinoma.

Supporting Evidence

  • The rhoC gene was significantly overexpressed in tumor tissues compared to non-malignant portions.
  • Patients with high rhoC expression had poorer survival rates.
  • Metastatic lesions showed higher rhoC expression than primary tumors.

Takeaway

This study found that a gene called rhoC is more active in pancreatic cancer, and when it's more active, patients tend to do worse.

Methodology

The study used RT-PCR to measure rho gene expressions in tumor tissues and compared them with non-malignant portions.

Limitations

The study could not compare matched pairs of primary and metastatic lesions.

Participant Demographics

Patients with ductal adenocarcinoma of the pancreas, ages ranging from 46 to 79.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication